RecruitingNCT06781463

Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis

Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis (GAE)


Sponsor

University of Chicago

Enrollment

100 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to create a prospective registry (\<100 patients) to show the effectiveness of the genicular artery embolization procedure overtime in reducing bilateral or unilateral osteoarthritic knee pain as measured by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Patients aged \>=18
  • Bilateral or unilateral knee pain attributed to knee osteoarthritis (KOA). For bilateral KOA patients, the more severe knee will be permitted inclusion to the registry
  • Grade 1-3 Osteoarthritis as diagnosed on standing weight-bearing knee radiographs per the Kellen-Lawrence Grading scale
  • Knee pain \>6 months refractory to conservative medical management (Nonsteroidal anti-inflammatory drugs, acetaminophen, etc.)
  • Not eligible for surgical knee replacement or patient's personal preference to undergo Genicular Artery Embolization (GAE) for reasons such as minimally invasiveness of GAE

Exclusion Criteria13

  • Active malignancy
  • Active infection of the affected knee
  • Platelets \<50,000/uL, INR \>2.0 (unless on anticoagulation that can be reversed or performing radial/pedal access without reversal)
  • Corticosteroid injection of the affected knee within 3 months of enrollment
  • Rheumatoid arthritis or other seronegative arthropathy
  • Previous surgery (excluding arthroscopy) of the affected knee
  • Grade 4 per Kellgren-Lawrence Grading Scale of the affected knee
  • Pregnancy or expected pregnancy
  • Glomerular Filtration Rate (GFR) \<30
  • Anaphylactic reaction to iodinated contrast
  • Moderate to severe pain in other lower limb joints
  • Body weight \>400 lbs. (prohibiting safe angiography)
  • Peripheral arterial disease of the treated extremity (Rutherford Grade 2 or greater)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRegistry (N/A)

This study is a registry, thus no research intervention is being directly tested.


Locations(1)

University of Chicago Duchossois Center for Advanced Medicine

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06781463


Related Trials